← All organizations

ID Biomedical Corporation, Quebec

For profit

Also known as: ID Biomedical Corporation of Quebec | ID Biomedical of Quebec

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 1, 2005

Acquired by GlaxoSmithKline on Sep 1, 2005

Timeline

1990s

Jan 1, 1991
ID Biomedical Corporation, Quebec— Founded

2000s

Sep 1, 2005
GlaxoSmithKline— Acquired By

Drugs by trial phase (1 distinct, 3 trials)

Phase 3 (1 own, 0 via acquisition)

inactivated influenza vaccine

Indications

Studied for

Influenza, Human

Recent trials (5)

NCT00232947Lead sponsorPhase 3Oct 1, 2005
NCT00232947Study directorPhase 3Oct 1, 2005
NCT00216242Lead sponsorPhase 3Sep 1, 2005
NCT00216242Study directorPhase 3Sep 1, 2005
NCT01389479CollaboratorPhase 3Jan 1, 2005

Details

Founded: Vancouver, CA Jan 1, 1991
Last known activity: Oct 1, 2005